β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.

Saved in:
Bibliographic Details
Title: β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.
Authors: LaFon DC; Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, The University of Alabama at Birmingham.; UAB Lung Health Center, Heersink School of Medicine, The University of Alabama at Birmingham., Helgeson ES; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis., Lindberg S; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis., Voelker H; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis., Bhatt SP; Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, The University of Alabama at Birmingham.; UAB Lung Health Center, Heersink School of Medicine, The University of Alabama at Birmingham., Casaburi R; Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California., Cassady SJ; Division of Pulmonary and Critical Care Medicine, University of Maryland, Baltimore., Connett J; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis., Criner GJ; Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania., Hatipoglu U; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio., Kaminsky DA; Pulmonary and Critical Care Medicine, University of Vermont, Burlington., Kunisaki KM; Minneapolis VA Health Care System, Minneapolis, Minnesota., Lazarus SC; Division of Pulmonary and Critical Care Medicine, University of California San Francisco.; Cardiovascular Research Institute, University of California San Francisco., McEvoy CE; Health Partners Institute, Minneapolis, Minnesota., Reed RM; Division of Pulmonary and Critical Care Medicine, University of Maryland, Baltimore., Sciurba FC; Division of Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Stringer W; Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California., Dransfield MT; Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, The University of Alabama at Birmingham.; UAB Lung Health Center, Heersink School of Medicine, The University of Alabama at Birmingham.; Birmingham VA Medical Center, Birmingham, Alabama.
Source: JAMA network open [JAMA Netw Open] 2024 May 01; Vol. 7 (5), pp. e247535. Date of Electronic Publication: 2024 May 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2574-3805
DOI:10.1001/jamanetworkopen.2024.7535